Korean J Pain.  2020 Oct;33(4):294-304. 10.3344/kjp.2020.33.4.294.

Etiopathogenesis of sacroiliitis: implications for assessment and management

• Baronio M
• Sadia H
• Paolacci S
• Prestamburgo D
• Miotti D
• Guardamagna VA
• Natalini G
• Bertelli M

• KMID: 2507135
• DOI: http://doi.org/10.3344/kjp.2020.33.4.294

Abstract

The sacroiliac joints connect the base of the sacrum to the ilium. When inflamed, they are suspected to cause low back pain. Inflammation of the sacroiliac joints is called sacroiliitis. The severity of the pain varies and depends on the degree of inflammation. Sacroiliitis is a hallmark of seronegative spondyloarthropathies. The presence or absence of chronic sacroiliitis is an important clue in the diagnosis of low back pain. This article aims to provide a concise overview of the anatomy, physiology, and molecular biology of sacroiliitis to aid clinicians in the assessment and management of sacroiliitis. For this narrative review, we evaluated articles in English published before August 2019 in PubMed. Then, we selected articles related to the painful manifestations of the sacroiliac joint. From the retrieved articles, we found that chronic sacroiliitis may be caused by various forms of spondyloarthritis, such as ankylosing spondyloarthritis. Sacroiliitis can also be associated with inflammatory bowel disease, Crohn’s disease, gout, tuberculosis, brucellosis, and osteoarthritis, indicating common underlying etiological factors. The pathophysiology of sacroiliitis is complex and may involve internal, environmental, immunological, and genetic factors. Finally, genetic factors may also play a central role in progression of the disease. Knowing the genetic pre-disposition for sacroiliitis can be useful for diagnosis and for formulating treatment regimens, and may lead to a substantial reduction in disease severity and duration and to improved patient performance.

Keyword

Inflammation; Inflammatory Bowel Diseases; Low Back Pain; Sacroiliac Joint; Sacroiliitis; Sacrum; Spondylitis; Ankylosing; Spondyloarthropathies

Reference

1. Buchanan BK, Varacallo M. 2020. Sacroiliitis [Internet]. StatPearls Publishing;Treasure Island (FL): Available at: http://www.ncbi.nlm.nih.gov/books/NBK448141/.

2. Rashbaum RF, Ohnmeiss DD, Lindley EM, Kitchel SH, Patel VV. 2016; Sacroiliac joint pain and its treatment. Clin Spine Surg. 29:42–8. DOI: 10.1097/BSD.0000000000000359. PMID: 26889985.

3. Dietrichs E. 1991; Anatomy of the pelvic joints--a review. Scand J Rheumatol Suppl. 88:4–6. PMID: 2011709.

4. Prather H, Hunt D. 2004; Conservative management of low back pain, part I. Sacroiliac joint pain. Dis Mon. 50:670–83. DOI: 10.1016/j.disamonth.2004.12.004. PMID: 15767995.

5. Solonen KA. 1957; The sacroiliac joint in the light of anatomical, roentgenological and clinical studies. Acta Orthop Scand Suppl. 27:1–127. DOI: 10.3109/ort.1957.28.suppl-27.01. PMID: 13478452.

6. McKenzie-Brown AM, Shah RV, Sehgal N, Everett CR. 2005; A systematic review of sacroiliac joint interventions. Pain Physician. 8:115–25.

7. Scholten PJ, Schultz AB, Luchies CW, Miller JA. 1988; Motions and loads within the human pelvis: a biomechanical model study. J Orthop Res. 6:840–50. DOI: 10.1002/jor.1100060608. PMID: 3171764.

8. Harrison DE, Harrison DD, Troyanovich SJ. 1997; The sacroiliac joint: a review of anatomy and biomechanics with clinical implications. J Manipulative Physiol Ther. 20:607–17. PMID: 9436146.

9. Vleeming A, Schuenke MD, Masi AT, Carreiro JE, Danneels L, Willard FH. 2012; The sacroiliac joint: an overview of its anatomy, function and potential clinical implications. J Anat. 221:537–67. DOI: 10.1111/j.1469-7580.2012.01564.x. PMID: 22994881. PMCID: PMC3512279.

10. Vleeming A, Pool-Goudzwaard AL, Hammudoghlu D, Stoeckart R, Snijders CJ, Mens JM. 1996; The function of the long dorsal sacroiliac ligament: its implication for understanding low back pain. Spine (Phila Pa 1976). 21:556–62. DOI: 10.1097/00007632-199603010-00005. PMID: 8852309.

11. Wong M, Sinkler M, Kiel J. 2020. Anatomy, abdomen and pelvis, sacroiliac joint [Internet]. StatPearls Publishing;Treasure Island (FL): Available at: http://www.ncbi.nlm.nih.gov/books/NBK507801/.

12. Becker I, Woodley SJ, Stringer MD. 2010; The adult human pubic symphysis: a systematic review. J Anat. 217:475–87. DOI: 10.1111/j.1469-7580.2010.01300.x. PMID: 20840351. PMCID: PMC3035856.

13. Vilensky JA, O'Connor BL, Fortin JD, Merkel GJ, Jimenez AM, Scofield BA, et al. 2002; Histologic analysis of neural elements in the human sacroiliac joint. Spine (Phila Pa 1976). 27:1202–7. DOI: 10.1097/00007632-200206010-00012. PMID: 12045518.

14. Cunningham DJ, Romanes GJ. 1981. Cunningham's textbook of anatomy. 12th ed. Oxford University Press;Oxford: p. 691–2.

15. Forst SL, Wheeler MT, Fortin JD, Vilensky JA. 2006; The sacroiliac joint: anatomy, physiology and clinical significance. Pain Physician. 9:61–7. PMID: 16700283.

16. Holm S, Indahl A, Solomonow M. 2002; Sensorimotor control of the spine. J Electromyogr Kinesiol. 12:219–34. DOI: 10.1016/S1050-6411(02)00028-7. PMID: 31151376.

17. Patel N, Gross A, Brown L, Gekht G. 2012; A randomized, placebo-controlled study to assess the efficacy of lateral branch neurotomy for chronic sacroiliac joint pain. Pain Med. 13:383–98. DOI: 10.1111/j.1526-4637.2012.01328.x. PMID: 22299761.

18. Alderink GJ. 1991; The sacroiliac joint: review of anatomy, mechanics, and function. J Orthop Sports Phys Ther. 13:71–84. DOI: 10.2519/jospt.1991.13.2.71. PMID: 18796854. PMCID: PMC7343255.

19. Kampen WU, Tillmann B. 1998; Age-related changes in the articular cartilage of human sacroiliac joint. Anat Embryol (Berl). 198:505–13. DOI: 10.1007/s004290050200. PMID: 9833689.

20. Rawlings CE 3rd, Wilkins RH, Martinez S, Wilkinson RH Jr. 1988; Osteoporotic sacral fractures: a clinical study. Neurosurgery. 22(1 Pt 1):72–6. DOI: 10.1227/00006123-198801000-00011. PMID: 2449628.

21. Prassopoulos PK, Faflia CP, Voloudaki AE, Gourtsoyiannis NC. 1999; Sacroiliac joints: anatomical variants on CT. J Comput Assist Tomogr. 23:323–7. DOI: 10.1097/00004728-199903000-00029. PMID: 10096348.

22. Andersson GB. 1999; Epidemiological features of chronic low-back pain. Lancet. 354:581–5. DOI: 10.1016/S0140-6736(99)01312-4.

23. Bernard TN, Cassidy JD. Frymoyer J, editor. 1991. The sacroiliac joint syndrome: pathophysiology, diagnosis and management. The adult spine: principles and practice. Raven Press;New York: p. 2107–30.

24. Verrills P, Vivian D. 2004; Interventions in chronic low back pain. Aust Fam Physician. 33:421–6.

25. Dreyfuss P, Dryer S, Griffin J, Hoffman J, Walsh N. 1994; Positive sacroiliac screening tests in asymptomatic adults. Spine (Phila Pa 1976). 19:1138–43. DOI: 10.1097/00007632-199405001-00007. PMID: 8059269. PMCID: PMC7316546.

26. Hill JA, Lombardo SJ. 1981; Ankylosing spondylitis presenting as shoulder pain in an athlete. A case report. Am J Sports Med. 9:262–4. DOI: 10.1177/036354658100900416. PMID: 7258470.

27. Kok HK, Mumtaz A, O'Brien C, Kane D, Torreggiani WC, Delaney H. 2016; Imaging the patient with sacroiliac pain. Can Assoc Radiol J. 67:41–51. DOI: 10.1016/j.carj.2015.08.001. PMID: 26632100.

28. Ramlakan RJ, Govender S. 2007; Sacroiliac joint tuberculosis. Int Orthop. 31:121–4. DOI: 10.1007/s00264-006-0132-9. PMID: 16673102. PMCID: PMC5708174.

29. Hanly JG, Mitchell MJ, Barnes DC, MacMillan L. 1994; Early recognition of sacroiliitis by magnetic resonance imaging and single photon emission computed tomography. J Rheumatol. 21:2088–95. PMID: 7869315.

30. Bakker P, Moltó A, Etcheto A, Van den Bosch F, Landewé R, van Gaalen F, et al. 2017; The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study. Arthritis Res Ther. 19:96. DOI: 10.1186/s13075-017-1281-5. PMID: 28511725. PMCID: PMC5434574.

31. Rudwaleit M, Jurik AG, Hermann KG, Landewé R, van der Heijde D, Baraliakos X, et al. 2009; Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis. 68:1520–7. DOI: 10.1136/ard.2009.110767. PMID: 19454404.

32. Tarantino A, Jablonska JP, D'Aprile P. 2018; All that glitters is not gold: sacroiliitis. Reumatologia. 56:289–93. DOI: 10.5114/reum.2018.79499. PMID: 30505010.

33. Zelle BA, Gruen GS, Brown S, George S. 2005; Sacroiliac joint dysfunction: evaluation and management. Clin J Pain. 21:446–55. DOI: 10.1097/01.ajp.0000131413.07468.8e. PMID: 16093751.

34. Cusi M, Saunders J, Van der Wall H, Fogelman I. 2013; Metabolic disturbances identified by SPECT-CT in patients with a clinical diagnosis of sacroiliac joint incompetence. Eur Spine J. 22:1674–82. DOI: 10.1007/s00586-013-2725-5. PMID: 23455953. PMCID: PMC3698330.

35. Klang E, Lidar M, Lidar Z, Aharoni D, Eshed I. 2017; Prevalence and awareness of sacroiliac joint alterations on lumbar spine CT in low back pain patients younger than 40 years. Acta Radiol. 58:449–55. DOI: 10.1177/0284185116656490. PMID: 27445315.

36. Song R, Lee S, Lee SH. 2019; Progressive sacroiliitis due to accessory sacroiliac joint mimicking ankylosing spondylitis: a case report. Medicine (Baltimore). 98:e15324. DOI: 10.1097/MD.0000000000015324. PMID: 31008988. PMCID: PMC6494240.

37. Toussirot E, Aubry S, Runge M. 2018; Unilateral accessory sacroiliac joint with bone marrow edema mimicking sacroiliitis. J Rheumatol. 45:1327–8. DOI: 10.3899/jrheum.180030. PMID: 30173180.

38. Chou LH, Slipman CW, Bhagia SM, Tsaur L, Bhat AL, Isaac Z, et al. 2004; Inciting events initiating injection-proven sacroiliac joint syndrome. Pain Med. 5:26–32. DOI: 10.1111/j.1526-4637.2004.04009.x. PMID: 14996234.

39. Itz CJ, Willems PC, Zeilstra DJ, Huygen FJ. 2016; Dutch multidisciplinary guideline for invasive treatment of pain syndromes of the lumbosacral spine. Pain Pract. 16:90–110. DOI: 10.1111/papr.12318. PMID: 26032119.

40. Prather H. 2003; Sacroiliac joint pain: practical management. Clin J Sport Med. 13:252–5. DOI: 10.1097/00042752-200307000-00010. PMID: 12855929.

41. Timm KE. 1999; Sacroiliac joint dysfunction in elite rowers. J Orthop Sports Phys Ther. 29:288–93. DOI: 10.2519/jospt.1999.29.5.288. PMID: 10342566. PMCID: PMC7505610.

42. Lindsay DM, Meeuwisse WH, Vyse A, Mooney ME, Summersides J. 1993; Lumbosacral dysfunctions in elite cross-country skiers. J Orthop Sports Phys Ther. 18:580–5. DOI: 10.2519/jospt.1993.18.5.580. PMID: 8268959.

43. Hill JJ, Keating JL. 2009; A systematic review of the incidence and prevalence of low back pain in children. Phys Ther Rev. 14:272–84. DOI: 10.1179/108331909X12488667116899.

44. Šarčević Z, Tepavčević A. 2019; Association between adolescent idiopathic scoliosis and sacroiliac joint dysfunction in young athletes: a case control study. Medicine (Baltimore). 98:e15161. DOI: 10.1097/MD.0000000000015161. PMID: 30985695. PMCID: PMC6485790.

45. Miller TL, Cass N, Siegel C. 2014; Ankylosing spondylitis in an athlete with chronic sacroiliac joint pain. Orthopedics. 37:e207–10. DOI: 10.3928/01477447-20140124-27. PMID: 24679210.

46. Polsunas PJ, Sowa G, Fritz JM, Gentili A, Morone NE, Raja SN, et al. 2016; Deconstructing chronic low back pain in the older adult-step by step evidence and expert-based recommendations for evaluation and treatment: part X: sacroiliac joint syndrome. Pain Med. 17:1638–47. DOI: 10.1093/pm/pnw151. PMID: 27605679.

47. Chakrabortty S, Kumar S, Gupta D, Rudraraju S. 2016; Intractable sacroiliac joint pain treated with peripheral nerve field stimulation. J Anaesthesiol Clin Pharmacol. 32:392–4. DOI: 10.4103/0970-9185.173336. PMID: 27625495. PMCID: PMC5009853.

48. Cairns KD, McRoberts WP, Deer T. 2011; Peripheral nerve stimulation for the treatment of truncal pain. Prog Neurol Surg. 24:58–69. DOI: 10.1159/000323025. PMID: 21422776. PMCID: PMC7496167.

49. Shim JH, Jeon WJ, Cho SY, Yeom JH, Shin WJ, Kim KH. 2003; Sacroiliac joint injection in patients with low back pain or buttock pain: short-term follow-up results. Korean J Pain. 16:175–80.

50. Simopoulos TT, Manchikanti L, Gupta S, Aydin SM, Kim CH, Solanki D, et al. 2015; Systematic review of the diagnostic accuracy and therapeutic effectiveness of sacroiliac joint interventions. Pain Physician. 18:E713–56. PMID: 26431129.

51. Scholten PM, Patel SI, Christos PJ, Singh JR. 2015; Short-term efficacy of sacroiliac joint corticosteroid injection based on arthrographic contrast patterns. PMR. 7:385–91. DOI: 10.1016/j.pmrj.2014.10.007. PMID: 25452127. PMCID: PMC4696761.

52. Mayo Foundation for Medical Education and Research. 2018. Sacroiliitis [Internet]. Mayo Foundation for Medical Education and Research;Rochester (MN): Available at: https://www.mayoclinic.org/diseases-conditions/sacroiliitis/diagnosis-treatment/drc-20350751.

53. Manchikanti L, Abdi S, Atluri S, Benyamin RM, Boswell MV, Buenaventura RM, et al. 2013; An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician. 16(2 Suppl):S49–283. PMID: 23615883.

54. Sachs D, Capobianco R. 2013; Minimally invasive sacroiliac joint fusion: one-year outcomes in 40 patients. Adv Orthop. 2013:536128. DOI: 10.1155/2013/536128. PMID: 23997957. PMCID: PMC3755432.

55. Sachs D, Kovalsky D, Redmond A, Limoni R, Meyer SC, Harvey C, et al. 2016; Durable intermediate-to long-term outcomes after minimally invasive transiliac sacroiliac joint fusion using triangular titanium implants. Med Devices (Auckl). 9:213–22. DOI: 10.2147/MDER.S109276. PMID: 27471413. PMCID: PMC4948694.

56. Rudolf L, Capobianco R. 2014; Five-year clinical and radiographic outcomes after minimally invasive sacroiliac joint fusion using triangular implants. Open Orthop J. 8:375–83. DOI: 10.2174/1874325001408010375. PMID: 25352932. PMCID: PMC4209504.

57. Vanaclocha V, Herrera JM, Sáiz-Sapena N, Rivera-Paz M, Verdú-López F. 2018; Minimally invasive sacroiliac joint fusion, radiofrequency denervation, and conservative management for sacroiliac joint pain: 6-year comparative case series. Neurosurgery. 82:48–55. DOI: 10.1093/neuros/nyx185. PMID: 28431026.

58. Brown CR, Reiner SL. 2000; Genes outside the major histocompatibility complex control resistance and susceptibility to experimental Lyme arthritis. Med Microbiol Immunol. 189:85–90. DOI: 10.1007/s004300000044. PMID: 11138641.

59. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. 1973; High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 288:704–6. DOI: 10.1056/NEJM197304052881403. PMID: 4688372.

60. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. 1973; Ankylosing spondylitis and HL-A 27. Lancet. 1:904–7. DOI: 10.1016/S0140-6736(73)91360-3.

61. Orchard TR, Holt H, Bradbury L, Hammersma J, McNally E, Jewell DP, et al. 2009; The prevalence, clinical features and association of HLA-B27 in sacroiliitis associated with established Crohn's disease. Aliment Pharmacol Ther. 29:193–7. DOI: 10.1111/j.1365-2036.2008.03868.x. PMID: 18945256.

62. Alkan S, Kayiran N, Zengin O, Kalem A, Kimyon G, Kilinc EO, et al. 2015; Isotretinoin-induced spondyloarthropathy-related symptoms: a prospective study. J Rheumatol. 42:2106–9. DOI: 10.3899/jrheum.150013. PMID: 26472411.

63. Faustini F, Zoli A, Ferraccioli GF. 2009; Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases. Eur Rev Med Pharmacol Sci. 13 Suppl 1:1–9. PMID: 19530505.

64. Eksioglu E, Oztekin F, Unlu E, Cakci A, Keyik B, Karadavut IK. 2008; Sacroiliitis and polyneuropathy during isotretinoin treatment. Clin Exp Dermatol. 33:122–4. DOI: 10.1111/j.1365-2230.2007.02532.x. PMID: 17725657.

65. Kaşifoğlu T, Calişir C, Cansu DU, Korkmaz C. 2009; The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. 28:41–6. DOI: 10.1007/s10067-008-0980-3. PMID: 18795391.

66. van de Loo FA, Joosten LA, van Lent PL, Arntz OJ, van den Berg WB. 1995; Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum. 38:164–72. DOI: 10.1002/art.1780380204. PMID: 7848306.

67. Dale M, Nicklin MJ. 1999; Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics. 57:177–9. DOI: 10.1006/geno.1999.5767. PMID: 10191101.

68. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, et al. 1993; Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science. 261:472–5. DOI: 10.1126/science.8332913. PMID: 8332913.

69. Jiang Y, Genant HK, Watt I, Cobby M, Bresnihan B, Aitchison R, et al. 2000; A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores. Arthritis Rheum. 43:1001–9. DOI: 10.1002/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P. PMID: 10817552.

70. McGarry F, Neilly J, Anderson N, Sturrock R, Field M. 2001; A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology (Oxford). 40:1359–64. DOI: 10.1093/rheumatology/40.12.1359. PMID: 11752505. PMCID: PMC7142766.

71. Zhang P, Li Q, Qi J, Lv Q, Zheng X, Wu X, et al. 2017; Association between vitamin D receptor gene polymorphism and ankylosing spondylitis in Han Chinese. Int J Rheum Dis. 20:1510–6. DOI: 10.1111/1756-185X.12949. PMID: 27778467.

72. Davidson SI, Jiang L, Cortes A, Wu X, Glazov EA, Donskoi M, et al. 2013; Brief report: high-throughput sequencing of IL23R reveals a low-frequency, nonsynonymous single-nucleotide polymorphism that is associated with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum. 65:1747–52. DOI: 10.1002/art.37976. PMID: 23606107.

73. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. 2007; Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 39:1329–37. DOI: 10.1038/ng.2007.17. PMID: 17952073. PMCID: PMC2680141.

74. Wellcome Trust Case Control Consortium. Australo-Anglo-American Spondylitis Consortium (TASC). 2006; A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 314:1461–3. DOI: 10.1126/science.1135245. PMID: 17068223. PMCID: PMC4410764.

75. Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, et al. 2009; Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 41:199–204. DOI: 10.1038/ng.311. PMID: 19169254. PMCID: PMC2745122.

76. Kadi A, Costantino F, Izac B, Leboime A, Said-Nahal R, Garchon HJ, et al. 2013; Brief report: the IL23R nonsynonymous polymorphism rs11209026 is associated with radiographic sacroiliitis in spondyloarthritis. Arthritis Rheum. 65:2655–60. DOI: 10.1002/art.38060. PMID: 23818276.

77. Gorman JD, Sack KE, Davis JC Jr. 2002; Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med. 346:1349–56. DOI: 10.1056/NEJMoa012664. PMID: 11986408.

78. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. 2002; Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet. 359:1187–93. DOI: 10.1016/S0140-6736(02)08215-6. PMID: 11955536.

79. Redlich K, Görtz B, Hayer S, Zwerina J, Kollias G, Steiner G, et al. 2004; Overexpression of tumor necrosis factor causes bilateral sacroiliitis. Arthritis Rheum. 50:1001–5. DOI: 10.1002/art.20194. PMID: 15022345.

80. Peeters H, Vander Cruyssen B, Laukens D, Coucke P, Marichal D, Van Den Berghe M, et al. 2004; Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease. Ann Rheum Dis. 63:1131–4. DOI: 10.1136/ard.2004.021774. PMID: 15308523.

81. Peeters H, Vander Cruyssen B, Mielants H, de Vlam K, Vermeire S, Louis E, et al. 2008; Clinical and genetic factors associated with sacroiliitis in Crohn's disease. J Gastroenterol Hepatol. 23:132–7. DOI: 10.1111/j.1440-1746.2007.05108.x.

82. Wright C, Sibani S, Trudgian D, Fischer R, Kessler B, LaBaer J, et al. 2012; Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol Cell Proteomics. 11:M9.00384. DOI: 10.1074/mcp.M9.00384. PMID: 22311593. PMCID: PMC3277774.

83. Zolnierowicz S. 2000; Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem Pharmacol. 60:1225–35. DOI: 10.1016/S0006-2952(00)00424-X. PMID: 11007961. PMCID: PMC4916389.

84. Duan X, Liang YY, Feng XH, Lin X. 2006; Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem. 281:36526–32. DOI: 10.1074/jbc.M605169200. PMID: 16931515.

85. Kim YG, Sohn DH, Zhao X, Sokolove J, Lindstrom TM, Yoo B, et al. 2014; Role of protein phosphatase magnesium-dependent 1A and anti-protein phosphatase magnesium-dependent 1A autoantibodies in ankylosing spondylitis. Arthritis Rheumatol. 66:2793–803. DOI: 10.1002/art.38763. PMID: 24980965. PMCID: PMC4198528.

86. Singh Sangha M, Wright ML, Ciurtin C. 2018; Strongly positive anti-CCP antibodies in patients with sacroiliitis or reactive arthritis post-E. coli infection: a mini case-series based review. Int J Rheum Dis. 21:315–21. DOI: 10.1111/1756-185X.13113. PMID: 28589668.

87. Prajzlerová K, Grobelná K, Hušáková M, Forejtová Š, Jüngel A, Gay S, et al. 2017; Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis. PLoS One. 12:e0185323. DOI: 10.1371/journal.pone.0185323. PMID: 28938006. PMCID: PMC5609864.

88. Huang J, Song G, Yin Z, Luo X, Ye Z. 2014; Elevated miR-29a expression is not correlated with disease activity index in PBMCs of patients with ankylosing spondylitis. Mod Rheumatol. 24:331–4. DOI: 10.3109/14397595.2013.854077. PMID: 24593209.

89. Li X, Lv Q, Tu L, Zhao M, Zhang P, Li Q, et al. 2019; Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis. Int J Rheum Dis. 22:1188–95. DOI: 10.1111/1756-185X.13563. PMID: 30990253.

90. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, et al. 1995; The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol. 22:2273–8. DOI: 10.1097/MD.0000000000016400. PMCID: PMC6641803. PMID: 8835562.

91. Alonso Farto JC, Arias IA, Lopez Longo FJ, Gonzalez Fernandez CM, Monteagudo Saez I, Ortega Valle A, et al. 2000; Clinical significance of abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondyloarthropathies. Eur J Nucl Med. 27:1768–73. DOI: 10.1007/s002590000393. PMID: 11189938.

92. Fox JG, Dewhirst FE, Fraser GJ, Paster BJ, Shames B, Murphy JC. 1994; Intracellular Campylobacter-like organism from ferrets and hamsters with proliferative bowel disease is a Desulfovibrio sp. J Clin Microbiol. 32:1229–37. DOI: 10.1128/JCM.32.5.1229-1237.1994. PMID: 8051249. PMCID: PMC263654.

93. Hannu T. 2011; Reactive arthritis. Best Pract Res Clin Rheumatol. 25:347–57. DOI: 10.1016/j.berh.2011.01.018. PMID: 22100285. PMCID: PMC7519381.

94. Schiellerup P, Krogfelt KA, Locht H. 2008; A comparison of self-reported joint symptoms following infection with different enteric pathogens: effect of HLA-B27. J Rheumatol. 35:480–7. PMID: 18203313.

95. Putterman C, Rubinow A. 1993; Reactive arthritis associated with Clostridium difficile pseudomembranous colitis. Semin Arthritis Rheum. 22:420–6. DOI: 10.1016/S0049-0172(05)80033-2. PMID: 8342048. PMCID: PMC4763550.

96. Stoll ML, Weiss PF, Weiss JE, Nigrovic PA, Edelheit BS, Bridges SL Jr, et al. 2018; Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther. 20:14. DOI: 10.1186/s13075-018-1510-6. PMID: 29382366. PMCID: PMC5791354.

97. Ebringer A. 1983; The cross-tolerance hypothesis, HLA-B27 and ankylosing spondylitis. Br J Rheumatol. 22(4 Suppl 2):53–66. DOI: 10.1093/rheumatology/XXII.suppl_2.53. PMID: 6418259.

98. Rath HC, Wilson KH, Sartor RB. 1999; Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun. 67:2969–74. DOI: 10.1128/IAI.67.6.2969-2974.1999. PMID: 10338507. PMCID: PMC96608.

99. Baeten D, De Keyser F, Mielants H, Veys EM. 2002; Immune linkages between inflammatory bowel disease and spondyloarthropathies. Curr Opin Rheumatol. 14:342–7. DOI: 10.1097/00002281-200207000-00002. PMID: 12118165.